Search Results - "Gallego, Rebecca A."
-
1
Lipophilic Efficiency as an Important Metric in Drug Design
Published in Journal of medicinal chemistry (09-08-2018)“…Lipophilic efficiency (LipE) is an important metric that has been increasingly applied in drug discovery medicinal chemistry lead optimization programs. In…”
Get full text
Journal Article -
2
Reviving B‑Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase
Published in ACS medicinal chemistry letters (13-09-2018)“…Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that can become oncogenic by activating mutations or overexpression. Full kinetic…”
Get full text
Journal Article -
3
An update on lipophilic efficiency as an important metric in drug design
Published in Expert opinion on drug discovery (02-08-2024)“…Lipophilic efficiency (LipE) and lipophilic metabolic efficiency (LipMetE) are valuable tools that can be utilized as part of a multiparameter optimization…”
Get more information
Journal Article -
4
Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation
Published in The Journal of biological chemistry (07-06-2019)“…Hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) is a Ser/Thr kinase that operates via the c-Jun N-terminal kinase (JNK) and extracellular signal-regulated…”
Get full text
Journal Article -
5
Design and Synthesis of Functionally Active 5‑Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1
Published in Journal of medicinal chemistry (13-04-2023)“…Immune activating agents represent a valuable class of therapeutics for the treatment of cancer. An area of active research is expanding the types of these…”
Get full text
Journal Article -
6
Discovery of Highly Selective Inhibitors of Microtubule-Associated Serine/Threonine Kinase-like (MASTL)
Published in Journal of medicinal chemistry (14-11-2024)“…By virtue of its role in cellular proliferation, microtubule-associated serine/threonine kinase-like (MASTL) represents a novel target and a first-in-class…”
Get full text
Journal Article -
7
Reviving B‑Factors: Retrospective Normalized B‑Factor Analysis of c‑ros Oncogene 1 Receptor Tyrosine Kinase and Anaplastic Lymphoma Kinase L1196M with Crizotinib and Lorlatinib
Published in ACS medicinal chemistry letters (13-09-2018)“…Structure-based drug design (SBDD) is commonly leveraged in rational drug design. Usually, ligand and binding site atomic coordinates from crystallographic…”
Get full text
Journal Article -
8
Reviving B-Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase
Published in ACS medicinal chemistry letters (09-08-2019)Get full text
Journal Article